Antiangiogenic Therapy Using Bevacizumab in Recurrent High-Grade Glioma: Impact on Local Control and Patient Survival

Journal of Neurosurgery - United States
doi 10.3171/2008.4.17492
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Journal of Neurosurgery Publishing Group (JNSPG)

Related search

Timing of Surgery and Bevacizumab Therapy in Neurosurgical Patients With Recurrent High Grade Glioma

Journal of Clinical Neuroscience
MedicineSurgeryNeurologyPhysiology
2015English

Impact of Health-Related Quality of Life and Fatigue on Survival of Recurrent High-Grade Glioma Patients

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2014English

The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients With High-Grade Glioma

Academic Radiology
Nuclear MedicineRadiologyImaging
2016English

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge

Cancer Research and Treatment
Cancer ResearchOncology
2016English

Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Use of Metformin and Survival of Patients With High-Grade Glioma

International Journal of Cancer
Cancer ResearchOncology
2018English

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma

World Journal of Oncology
Cancer ResearchOncology
2014English

Phase II Study of Bevacizumab and Vorinostat for Patients With Recurrent World Health Organization Grade 4 Malignant Glioma

Oncologist
Cancer ResearchMedicineOncology
2017English

Ultrasmall Theranostic Gadolinium-Based Nanoparticles Improve High-Grade Rat Glioma Survival

Journal of Clinical Neuroscience
MedicineSurgeryNeurologyPhysiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy